The move will bring enormous tax benefits to medical marijuana producers and may speed research into its effects, experts say ...

With medical marijuana set for reclassification into Schedule III, Midwest businesses could see major impacts in doing ...

Tilray Brands stock price crashed to its lowest level since August last year despite the recent US policy change that opened ...

The Drug Enforcement Administration’s rescheduling of marijuana will move it from its current classification as a Schedule I drug, defined as having a high risk for abuse and no ...

The reclassification of cannabis as a Schedule III substance is meant to remove barriers for researchers but its effects ...

CHICAGO - A major shift in federal marijuana policy could have a big impact on Illinois’ cannabis industry. The Trump ...

Most Americans support cannabis reform, but new research shows many believe rescheduling to Schedule III does not go far ...

The federal government’s reclassification of medical marijuana products as Schedule III drugs doesn’t federally legalize marijuana, but it might extend tax breaks to some cannabis businesses. The ...

AUSTIN (Nexstar) — Dr. Francesca Filbey, a professor of psychology at the University of Texas at Dallas, has studied the effects of cannabis on the human brain for more than a decade. Her work focuses ...

Acting Attorney General Todd Blanche signed an order under President Trump’s direction on Thursday to reclassify state-licensed medical marijuana as a less-dangerous drug — a major change in U.S.